ESR1 and Obesity: Obesity in postmenopausal women is a risk factor for the development of estrogen receptor positive (ERα)/luminal BC subtypes [7]; it is associated with a worse prognosis, worse disease-free survival and overall survival in comparison to women of normal body mass index (BMI) [7, 8].